Sernova Retains FronTier Merchant Capital for North America Investor Relations and Marketing
August 15, 2017 06:00 ET
|
Sernova Corp
LONDON, ONTARIO, Aug. 15, 2017 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), a leading clinical stage regenerative medicine company, is pleased to announce that it has...
Sernova-HemAcure Consortium Announce Significant Progress in Development of ‘First in World’ Regenerative Medicine Therapy for Treatment of Hemophilia A Patients
July 24, 2017 06:00 ET
|
Sernova Corp
LONDON, Ontario, July 24, 2017 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), a clinical stage regenerative medicine company, announced today significant scientific progress...
Sernova Provides Company Outlook on Corporate and Clinical Developments
June 05, 2017 06:00 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - June 5, 2017) - Sernova Corp. (TSX VENTURE:SVA)(FRANKFURT:PSH)(OTCQB:SEOVF), a clinical stage company developing medical technologies for the long-term...
Sernova Receives Approval to Extend Term of Warrants
May 05, 2017 06:00 ET
|
Sernova Corp.
LONDON, ONTARIO--(Marketwired - May 5, 2017) - Sernova Corp. (TSX VENTURE:SVA)(OTCQB:SEOVF)(FRANKFURT:PSH), a clinical stage regenerative medicine company, is pleased to announce that it...
Sernova to Present Corporate and JDRF-Sponsored Clinical Trial Update at the Biotech Showcase(TM) 2017 Healthcare Conference in San Francisco
December 22, 2016 06:00 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - Dec. 22, 2016) - Sernova Corp. (TSX VENTURE:SVA)(OTCQB:SEOVF)(FRANKFURT:PSH), a clinical stage regenerative medicine company, is pleased to announce that...
Sernova and CTI Clinical Trial Announce Regulatory Collaboration
November 02, 2016 06:00 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - Nov. 2, 2016) - Sernova Corp. (TSX VENTURE:SVA)(OTCQB:SEOVF)(FRANKFURT:PSH), a clinical stage company developing disruptive regenerative medicine...
Sernova Announces Appointment of New CFO
September 30, 2016 06:02 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - Sept. 30, 2016) - Sernova Corp. (TSX VENTURE:SVA)(OTCQB:SEOVF)(FRANKFURT:PSH), a clinical stage company developing disruptive regenerative medicine...
Sernova and JDRF Announce Funding of Joint Research Collaboration to Advance Human Clinical Trials for the Treatment of Hypoglycemic Unawareness Patients with Severe Type 1 Diabetes
July 12, 2016 06:00 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - July 12, 2016) - Sernova Corp. (TSX VENTURE:SVA)(OTCQB:SEOVF)(FRANKFURT:PSH), a clinical stage company developing disruptive regenerative medicine...
Sernova Completes Private Placement of $4,200,000
June 30, 2016 18:23 ET
|
Sernova Corp.
LONDON, ONTARIO--(Marketwired - June 30, 2016) - Sernova Corp. ("Sernova" or the "Company") (TSX VENTURE:SVA)(OTCQB:SEOVF)(FRANKFURT:PSH) is pleased to announce that it has completed a...
CORRECTION FROM SOURCE: Sernova Increases Private Placement to $4,200,000
June 29, 2016 09:16 ET
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - June 29, 2016) -
This document corrects and replaces the press release that was sent today at 06:15 ET.
Sernova Corp. ("Sernova" or the...